Showing results (101-110 of 147) with videos related to
Sort By:
Pageof 15
European Journal of Heart Failure|November 22, 2020
Ventricular tachycardia, premature ventricular contractions, and mortality in unselected patients with lung, colon, or pancreatic cancer: a prospective studyMarkus S Anker, Stephan von Haehling, Andrew J S Coats, et al.Cancers|July 2, 2021
Primary Thromboprophylaxis in Patients with Malignancies: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO)Martin Kirschner, Nicole do Ó Hartmann, Stefani Parmentier, et al.Journal of Immunology Research|April 18, 2014
Fcγ-receptor IIIA polymorphism p.158F has no negative predictive impact on rituximab therapy with and without sequential chemotherapy in CD20-positive posttransplant lymphoproliferative disorderHeiner Zimmermann, Theresa Weiland, Jamie P Nourse, et al.Cancer Medicine|July 15, 2020
Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI studySaroj Vadhan-Raj, Mairéad G McNamara, Marino Venerito, et al.Pathology, Research and Practice|July 28, 2016
P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcitabine treatmentJana K Striefler, Marianne Sinn, Uwe Pelzer, et al.Journal of the American College of Cardiology|September 27, 2014
Cardiovascular function and predictors of exercise capacity in patients with colorectal cancerLarissa Cramer, Bert Hildebrandt, Thomas Kung, et al.JAMA|October 10, 2013
Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trialHelmut Oettle, Peter Neuhaus, Andreas Hochhaus, et al.British Journal of Cancer|May 15, 2018
Tumour buds determine prognosis in resected pancreatic ductal adenocarcinomaPhilipp Lohneis, Marianne Sinn, Fritz Klein, et al.Journal of Clinical Medicine|August 26, 2022
Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer-The CONKO-008 Phase I InvestigationJana K Striefler, Jens M Stieler, Christopher C M Neumann, et al.Oncology Research and Treatment|December 28, 2021
Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry StudyRobert Klamroth, Marianne Sinn, Christiane Pollich, et al.Pageof 15